- By insider

COO of Krystal Biotech Inc (30-Year Financial, Insider Trades) Suma Krishnan (insider trades) sold 50,000 shares of KRYS on 09/17/2020 at an average price of $46.37 a share. The total sale was $2.3 million.

• Warning! GuruFocus has detected 1 Warning Sign with KRYS. Click here to check it out.

• KRYS 15-Year Financial Data

• The intrinsic value of KRYS

• Peter Lynch Chart of KRYS

Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders. Krystal Biotech Inc has a market cap of $909.460 million; its shares were traded at around $46.25 . GuruFocus has detected 1 severe warning sign with Krystal Biotech Inc. .

Directors and Officers Recent Trades:

• COO, 10% Owner Suma Krishnan sold 50,000 shares of KRYS stock on 09/17/2020 at the average price of $46.37. The price of the stock has decreased by 0.26% since.

For the complete insider trading history of KRYS, click here

.This article first appeared on GuruFocus.